Cargando…
WNT‐5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells
An important role for WNT‐5A is implicated in a variety of tumors, including breast carcinoma. We previously showed that WNT‐5A signaling inhibits migration and metastasis of breast cancer cells, and that patients with primary breast cancer in which WNT‐5A was expressed have a better prognosis. Desp...
Autores principales: | Prasad, Chandra Prakash, Chaurasiya, Shivendra Kumar, Axelsson, Lena, Andersson, Tommy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528454/ https://www.ncbi.nlm.nih.gov/pubmed/23727359 http://dx.doi.org/10.1016/j.molonc.2013.04.005 |
Ejemplares similares
-
WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition
por: Prasad, Chandra Prakash, et al.
Publicado: (2016) -
Cdc42 Inhibits ERK-mediated Collagenase-1 (MMP-1) Expression in Collagen-Activated Human Keratinocytes
por: Rohani, Maryam G., et al.
Publicado: (2013) -
Interleukin‐6 drives melanoma cell motility through p38α‐MAPK‐dependent up‐regulation of WNT5A expression
por: Linnskog, Rickard, et al.
Publicado: (2014) -
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
por: Prasad, Chandra Prakash, et al.
Publicado: (2015) -
WNT5A as a therapeutic target in breast cancer
por: Prasad, Chandra Prakash, et al.
Publicado: (2018)